MG01CI 1400 mg Compared With Placebo for ADHD
This study is completed in the United States and in Israel. It is testing MG01CI 1400 mg Compared With Placebo for ADHD.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States and in Israel. It is testing MG01CI 1400 mg Compared With Placebo for ADHD.
This study is completed in China. It is testing sulforaphane Effects for schizophrenia.
This study is ongoing in the United Kingdom. It is testing efficacy of Lurasidone Adjunctive Therapy for Bipolarity.
This study is completed in South Korea. It is testing Lurasidone HCL for schizophrenia.
This study has public registry information in Global. It is testing Safety and Efficacy of Methylphenidate HCl ERCT for ADHD.
This study has public registry information in Global. It is testing Safety and Efficacy of Quillichew ERCT for ADHD.
This study is active but not recruiting. It focuses on depression and currently lists study information in the United States.
This study is completed. It focuses on ADHD and currently lists study information in Turkey.
This study is completed. It focuses on schizophrenia and currently lists study information in the United States.
This study has public registry information. It focuses on anxiety and currently lists study information in Israel.
This study is completed. It focuses on bipolarity and currently lists study information in Taiwan.
This study is completed. It focuses on schizophrenia and currently lists study information in Canada.